Catalyst
Slingshot members are tracking this event:
PDUFA target date set to July 23, 2017 for Eagle Pharma's(EGRX) Ryanodex in treating Exertional Heat Stroke (EHS)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| EGRX | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jul 26, 2017
Occurred Source:
http://investor.eagleus.com/press-release/eagle-pharmaceuticals-receives-complete-response-letter-fda-ryanodex-exertional-heat-s
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Pdufa Date, Ryanodex, Exertional Heat Stroke
